Effects of modern chondroprotectors in osteoarthritis

Abstract

Osteoarthritis (OA) unites a group of diseases of the joints of various etiology causing deterioration and gradual loss of the articular cartilage. Osteoarthritis is the highest-ranking disease among the musculoskeletal diseases. According to WHO, osteoarthritis affects more than 4% of the world population, in 10% of cases causing disability, deterioration in the quality of life and social disadaptation of patients.

Keywords

• остеоартроз
• суставной хрящ
• хондроциты
• симптом-модифицирующие препараты замедленного действия
• хондроитина сульфат
• глюкозамин
• osteoarthritis
• articular cartilage
• chondrocytes
• slow acting symptom-modifying drugs
• chondroitin sulfate
• glucosamine sulfate